Tapley Holland, PhD
CEO and Founder, TruDOSE™

PANS/PANDAS, Platelets, and Immune Resilience: Exploring Precision Platelet Therapy as a Novel Immunomodulatory Approach in Neuroimmune Disease

PANS/PANDAS are complex neuroimmune disorders characterized by dysregulated inflammatory, immune, and neuropsychiatric signaling.

This presentation explores a regenerative medicine framework in which platelets function as endogenous cellular adaptogens capable of modulating immune activity, supporting tissue repair, and promoting physiological resilience.

Clinical observations from precision-dosed TruDOSE™ platelet therapy in pediatric patients with persistent immune dysregulation will be presented, including early improvements across behavioral, cognitive, social, sensory, neurological, and sleep domains.

Long-term follow-up demonstrated greater than 65% average improvement in overall symptom severity and functional impairment following a series of treatments. Preliminary analyses also suggest favorable trends in inflammatory and immune-related biomarkers.

The discussion will examine platelet-mediated communication networks and their potential role in neuroimmune regulation, immune resilience, and functional recovery.

Learning Objectives

• Understand how platelets function as endogenous cellular adaptogens that influence immune regulation, inflammation, tissue repair, and systemic resilience.

• Explore how precision-dosed platelet therapies may affect neuropsychiatric symptoms, functional outcomes, and biological markers in patients with PANS/PANDAS.

• Examine how platelet-mediated signaling networks may provide a new framework for immunomodulation and regenerative medicine in complex neuroimmune disorders.